Delivery Order SPE2DX22D0010-SPE2D825FHT55
Award Date 8/19/25
Potential Completion Date 8/20/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $17.4K delivery order to AmerisourceBergen Drug Corp for the supply of Vyvanse capsules (40mg) under a firm fixed-price contract. The delivery order, issued on August 5, 2025, represents a non-competitive, competitively awarded transaction with a completion deadline of August 6, 2025. AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania will serve as the place of performance for this pharmaceutical supply delivery....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Vyvanse capsules 70mg, with a ceiling value of $9,638.76. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's competitive...
- The Defense Logistics Agency awarded a Delivery Order valued at $7,765.80 to AmerisourceBergen Drug Corp for the supply of Vyvanse 20 mg capsules (100-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price contract specifies Conshohocken, Pennsylvania as the place of performance and carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Vyvanse 50 mg capsules (100-count units) at a firm fixed price with a ceiling value of $10,200.12. This competitively awarded, non-set-aside contract is scheduled for completion by July 24, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,339.21 to AmerisourceBergen Drug Corp for Vyvanse 50 mg capsules (100-count packages) on July 21, 2025, with an ultimate completion date of July 22, 2025. The contract employs firm fixed pricing and is not set aside for any specific business category. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal healthcare vendor specializing in...
- The Defense Logistics Agency awarded a delivery order valued at $8,072.36 to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Vyvanse 20 mg capsules (100-count units). This is a firm fixed-price, non-set-aside contract with a completion date of August 18, 2025, and performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for Vyvanse 30 mg capsules (quantity: 100s) valued at $6,670.67 with a completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government,...
- The Defense Logistics Agency awarded a delivery order valued at $14,112.20 to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Vyvanse 50 mg capsules (100-count units). This competitively awarded, firm fixed-price contract is scheduled for ultimate completion by August 18, 2025, with performance conducted at the vendor's Conshohocken, Pennsylvania location. The contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Vyvanse 30 mg capsules (100-count) with a contract value of $2,117.56 and completion date of July 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency Medical Supply Chain awarded a $15,113.78 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Vyvanse capsules 70mg, with performance through August 12, 2025. This firm fixed-price delivery order carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...